New £400,000 melanoma vaccine heralds start of 'cancer renaissance' as UK trials personalised jabs for lung, bowel, pancreas and liver tumours... but experts fear NHS can't afford them
The UK is entering a ' cancer renaissance' with pioneering personalised vaccines to combat some of the deadliest tumours expected by 2030, say leading experts. (Source: the Mail online | Health)
Source: the Mail online | Health - April 26, 2024 Category: Consumer Health News Source Type: news
Dual-tracer PET/CT shows promise in liver cancer patients
Dual-tracer PET/CT appears valuable for improving tumor staging in patients with hepatocellular carcinoma being evaluated for treatment, according to a study published April 25 in JHEP Reports.
A group led by researchers at the University of Hong Kong in China found the approach detected 12% more disease in patients undergoing staging than CT or MRI and resulted in a change in treatment in a significant number of cases. The results validate the emerging technique, the group noted.
“In a large series of patients, we provided quantitative evidence for the use of combined F-18 FDG and C-11 acetate PET/CT in staging HCC pa...
Source: AuntMinnie.com Headlines - April 26, 2024 Category: Radiology Authors: Will Morton Tags: Molecular Imaging Source Type: news
MASLD Plus HIV Ups Risk for CVD But Not Liver Disease MASLD Plus HIV Ups Risk for CVD But Not Liver Disease
A large study reveals an increased risk for adverse cardiovascular events but not for liver disease progression in adults with MASLD disease and HIV infection.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 26, 2024 Category: Consumer Health News Tags: Gastroenterology Clinical Summary Source Type: news
Gilead posts quarterly loss, revenue rises 5%
Gilead Sciences reported a first-quarter loss on Thursday after taking a $3.9 billion charge for its recent acquisition of liver drug developer CymaBay Therapeutics, while revenue rose 5% on higher HIV, oncology and liver disease treatment sales. For full-year 2024, Gilead said it still expects…#gileadsciences #cymabaytherapeutics #gilead #cymabay #immunomedics #danieloday (Source: Reuters: Health)
Source: Reuters: Health - April 25, 2024 Category: Consumer Health News Source Type: news
Houston Transplant Scandal: Families of Patients Who Died Begin Legal Action
(MedPage Today) -- Several relatives of patients who died while waiting for a new liver said Wednesday they want to know if their loved ones were wrongfully denied a transplant by a Houston doctor accused of manipulating the waitlist to make some... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - April 25, 2024 Category: American Health Source Type: news
A Test Told Me I ’m Basically Made of Plastic. You Probably Are Too
I might like to think of my body as a thing of bone and blood and tissue and water, but as I recently learned, it’s also a thing of plastic—home to an alarming amount of plastic toxins known as bisphenols. Used to manufacture mostly hard, durable plastics—such as water bottles and takeout containers—bisphenols are often found in the company of phthalates, which are used to make more flexible plastics such as raincoat linings, vinyl boots, and packing tape. Both types of chemicals are known to be hormone disruptors, leading to numerous health problems, including early puberty, obesity, heart disease,...
Source: TIME: Health - April 25, 2024 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized Environment Source Type: news
Study identifies driver of liver cancer that could be target for treatment
Inhibiting a certain protein in mice reduced obesity-induced liver tumor development, Yale researchers found. It could reveal a future treatment route. (Source: Yale Science and Health News)
Source: Yale Science and Health News - April 25, 2024 Category: Universities & Medical Training Source Type: news
Relatives of those who died waiting for livers at now halted Houston transplant program seek answers
Several relatives of patients who died while awaiting a new liver say they want to know if their loved ones were wrongfully denied a transplant by a Houston doctor accused of manipulating a hospital waitlist (Source: ABC News: Health)
Source: ABC News: Health - April 25, 2024 Category: Consumer Health News Tags: Health Source Type: news
Four red flag signs of silent killer disease one in three Brits at risk of having
One third of adults are thought to be in the early stages of the disease due to having fat in their liver. (Source: Daily Express - Health)
Source: Daily Express - Health - April 23, 2024 Category: Consumer Health News Source Type: news
Deep-learning algorithm improves liver fibrosis diagnosis
An algorithm combining the Fibrosis-4 Index (FIB-4) and an ultrasound deep-learning model could improve diagnostic accuracy and referral management for all-cause advanced liver fibrosis, a study published April 23 in Radiology found.
Researchers led by Li-Da Chen, PhD, from the First Affiliated Hospital of Sun Yat-sen University in Guangzhou, China found that their combined sequential algorithm improved specificity by over 20% for predicting pathologically advanced liver fibrosis compared with the Fibrosis-4 Index (FIB-4) alone. Additionally, the algorithm reduced unnecessary referrals by 42% without requiring access to l...
Source: AuntMinnie.com Headlines - April 23, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Ultrasound Artificial Intelligence Source Type: news
Inspired by her mother, career, transplant nurse altruistically becomes organ donor
Stephanie Donelan recovers following kidney donation surgery Each April, the country celebrates Donate Life Month, an observance to raise awareness about the importance of organ donation, celebrating donors' incredible generosity and inspiring others to consider becoming organ donors. It is also a time to celebrate the unique contributions transplant nurses make to the lives of their patients. Inspired by her work and her mother, Stephanie Donelan, a post-liver transplant coordinator at Mayo Clinic in Florida,… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 23, 2024 Category: Databases & Libraries Source Type: news
Top Pharmaceutical Company evaluates Optimer for precision liver medicine
Optimer delivery vehicle has been shipped to a pharma partner for external evaluation. The specific delivery vehicle could generate new precision therapies for liver disease (Source: The Scientist)
Source: The Scientist - April 22, 2024 Category: Science Tags: The Scientist The Marketplace Source Type: news
Assessing the clinical efficacy of low-volume therapeutic plasma exchange in achieving recovery from acute liver failure induced by yellow phosphorous poisoning - Ninan A, Mohan G, Shanbhag V, Chenna D, Shastry S, Rao S.
This study assessed low volume therapeutic plasma exchange (LV-TPE) efficacy in impr... (Source: SafetyLit)
Source: SafetyLit - April 22, 2024 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
UK biotech signs $1bn deal to develop liver disease drugs
Ochre Bio partnering with Germany’s Boehringer Ingelheim on treatments that will harness the organ’s capacity to regenerate (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 22, 2024 Category: Pharmaceuticals Source Type: news
What do you know about malaria?
Editors note: World Malaria Day will be observed Thursday, April 25. Malaria is caused by a single-celled parasite of the genus Plasmodium. The parasite is transmitted to humans most commonly through mosquito bites. The malaria parasites enter the bloodstream and travel to the liver. When the parasites mature, they leave the liver and infect red blood cells. This is when people typically develop malaria symptoms. Because the parasites that cause malaria affect red blood cells, people also can be infected… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 22, 2024 Category: Databases & Libraries Source Type: news
